Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?

Thomas M Kessler1, Helmut Madersbacher, Gustav Kiss

  • 1Neuro-Urology Unit, Department of Neurology, University Hospital Innsbruck, 6020 Innsbruck, Austria.

European Urology
|April 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 'FUTURE' of urodynamics in the management of female overactive bladder symptoms.

BJU international·2026
Same author

The Evidence-based Role of Urodynamics in Men with Lower Urinary Tract Symptoms Considering Prostate Surgery: An International Expert Consensus.

European urology focus·2026
Same author

RE: Comment: 'Male sex is a risk factor for detrusor pressure jeopardising the upper urinary tract in patients with spinal cord injury'.

BJU international·2025
Same author

Assessing sexual function in neurorehabilitation: insights and challenges from a spinal cord injury cohort.

The journal of sexual medicine·2025
Same author

Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study.

Lancet (London, England)·2025
Same author

Lower urinary tract sensory assessments in patients with neurogenic lower urinary tract dysfunction undergoing sacral neuromodulation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025
Same journal

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
See all related articles

Prolonged sacral neuromodulation testing with permanent leads improves patient selection for implantable pulse generators (IPG). This extended testing period increases successful implantation rates compared to standard short-term evaluations.

Area of Science:

  • Urology
  • Neurology
  • Medical Devices

Background:

  • Sacral neuromodulation (SNM) is a treatment for lower urinary tract dysfunction.
  • Current SNM testing protocols involve a short evaluation period (4-7 days).
  • The efficacy of SNM depends on accurate patient selection.

Purpose of the Study:

  • To compare the effectiveness of prolonged SNM testing (≥14 days) versus standard testing (4-7 days) using permanent leads.
  • To evaluate the impact of prolonged testing on patient selection for SNM.

Main Methods:

  • Retrospective analysis of 20 patients undergoing prolonged SNM testing with permanent leads.
  • Patients had urgency-frequency, urge incontinence, or chronic urinary retention.
  • Bladder diary variables were compared at baseline, after usual testing, prolonged testing, and follow-up.

Related Experiment Videos

Main Results:

  • Prolonged SNM testing significantly increased eligibility for implantable pulse generator (IPG) implantation from 50% to 80% (p=0.031).
  • 80% of patients completed successful prolonged testing and proceeded to IPG implantation.
  • At a median follow-up of 22 months, SNM was successful in 88% of implanted patients.

Conclusions:

  • Prolonged SNM testing with permanent leads enhances patient selection accuracy.
  • This extended testing method is more reliable than standard short-term evaluations.
  • Prolonged SNM testing is recommended as a standard procedure for SNM patient selection.